MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2022 International Congress

September 15-18, 2022. Madrid, Spain.

View by Title View Categories
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • Preclinical characterization of UCB0022, an oral, brain penetrant, selective, clinical-stage positive allosteric modulator of the dopamine 1 receptor (D1 PAM)

    C. Vermeiren, A. Ates, F. Bouzom, A. Delaunois, M. Gillard, B. Kenda, A. Ousset, L. Provins, D. Skolc, A. Valade, M. Vanmeulder, M. Wood, Y. Lamberty (Braine-l'Alleud, Belgium)

  • Predicting cognitive decline using neuropsychiatric symptoms in prodromal Lewy body disease.

    L. Wright, P. Donaghy, D. Burn, J-P. Taylor, J. O'Brien, A. Yarnall, F. Matthews, M. Firbank, A. Thomas, R. Lawson (Newcastle upon Tyne, United Kingdom)

  • Predicting the development of dementia in patients with Parkinson’s disease by comparing neurosteroids in the blood level

    DI. Okhunova, G. Sattarovna, A. Babokhujaev (Tashkent, Uzbekistan)

  • Prediction of early-stage Parkinson’s disease using connectivity and morphometry of the striatum

    D. Henadeerage Don, E. Alushaj, N. Handfield-Jones4, A. Khan, P. Macdonald (London, Canada)

  • Predictive factors for a favorable STN-DBS outcome in Parkinson’s Disease: the role of axial symptoms

    C. Ledda, C. Artusi, G. Imbalzano, M. Bozzali, M. Rizzone, A. Romagnolo, M. Zibetti, L. Lopiano (Turin, Italy)

  • Predictors of loss to follow-up three years after inclusion in a prospective longitudinal cohort study in people with early Parkinson’s disease

    C. Pauly, AM. Hanff, G. Aguayo, A. Rauschenberger, A. Leist, C. Mccrum, M. Zeegers, R. Krüger (Luxembourg, Luxembourg)

  • Predictors of relapse in impulse control disorders in patients with Parkinson’s disease.

    L. Gaibor, D. Vazquez, H. Estrada (CDMX, Mexico)

  • Predictors of short-term anxiety outcome after subthalamic stimulation in Parkinson’s Disease

    A. Sauerbier, V. Stopic, J. Herberg, P. Loehrer, K. Ashkan, A. Rizos, S. Jost, JN. Petry-Schmelzer, S. Heil, A. Gronostay, M. Barbe, V. Visser-Vandewalle, J. Evans, C. Nimsky, G. Fink, A. Antonini, P. Martinez-Martin, M. Silverdale, D. Weintraub, A. Schrag, K. Ray Chaudhuri, L. Timmermann, H. Dafsari (Cologne, Germany)

  • Predictors of the change in burden and strain among caregivers of Parkinson’s disease patients

    C. Cores Bartolomé, D. Santos García, T. Fonticoba, M. Feal Painceiras, E. Suarez Castro, C. Martinez Miro, S. Jesus Maestre, M. Aguilar, P. Pastor, L. Planellas, M. Cosgaya, J. Garcia Caldentey, N. Caballol, I. Legarda, J. Hernandez Vara, I. Cabo, L. Lopez Manzanares, I. Gonzalez Aramburu, MA. Avila Rivera, V. Gomez Mayordomo, V. Nogueira, V. Puente, J. Garcia-Soto, C. Borrue, B. Solano Vila, M. Alvarez Sauco, L. Vela, S. Escalante, E. Cubo, F. Carrillo Padilla, JC. Martinez Castrillo, P. Sanchez Alonso, MG. Alonso Losada, MI. Morales Casado, I. Gaston, J. Kulisevsky, M. Blazquez Estrada, M. Seijo, J. Ruiz Martinez, C. Valero, M. Kurtis, O. de Fabregues, J. Gonzalez Ardura, R. Alonso Redondo, C. Ordas, LM. Lopez Diaz, D. Mcafee, P. Martinez Martin, P. Mir (A CORUÑA, Spain)

  • Preferences for discussing sexual health concerns

    G. Bronner, S. Peleg Nesher, Y. Manor, A. Rosenberg, S. Naor, A. Ezra, R. Mallin, R. Hurvitz Alon, T. Gurevich (Tel Aviv, Israel)

  • « Previous Page
  • 1
  • …
  • 110
  • 111
  • 112
  • 113
  • 114
  • …
  • 153
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Survey-Based study of marijuana used in Parkinson’s Disease patients
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Life expectancy with and without Parkinson’s disease in the general population
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley